RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women

被引:0
|
作者
Ana M. Krivokuca
Emina J. Malisic
Jelena D. Dobricic
Ksenija V. Brotto
Milena R. Cavic
Radmila N. Jankovic
Zorica I. Tomasevic
Mirjana V. Brankovic-Magic
机构
[1] Institute for Oncology and Radiology of Serbia,Department of Experimental Oncology
[2] Institute of Oncology and Radiology of Serbia,Clinic of Medical Oncology
来源
Familial Cancer | 2014年 / 13卷
关键词
Breast cancer; DNA repair; Polymorphisms;
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer is a complex disease with both genetic and environmental factors involved in its etiology. An important role of polymorphisms in genes involved in DNA repair has been reported related to breast cancer risk. We conducted a case–control study in order to investigate the association of RAD51 135G>C and TP53 Arg72Pro polymorphisms with breast cancer in Serbian women.48 BRCA negative women with breast cancer and family history of breast/ovarian cancer (hereditary group), 107 women with breast cancer but without family history of the disease (sporadic group) and 114 healthy women without a history of the disease (control group) were included. Restriction fragment length polymorphism was used for genotyping. Genotype and allelic frequencies, the odds ratio (OR) and the 95 % confidence interval (CI) were calculated as an estimate of relative risk. The Hardy–Weinberg equilibrium was tested using χ2 test. Significance was considered for p < 0.05. RAD51 135G>C showed statistically significant association of CC genotype and increased breast cancer risk (OR 10.28, 95 % CI 1.12–94.5) in hereditary group of patients compared to the control group. Regarding the TP53 Arg72Pro, we showed statistical significance for ProPro + ProArg comparing to ArgArg (OR 2.34, 95 %, CI 1.17–4.70) in hereditary compared to sporadic group. RAD51 135G>C contributes to hereditary breast cancer in Serbian population, with CC genotype as a risk factor. We also found that carriers of Pro allele of TP53 codon 72 is related to hereditary cancer comparing to sporadic one, which indicates it as a potential risk factor for hereditary form of disease.
引用
收藏
页码:173 / 180
页数:7
相关论文
共 50 条
  • [21] Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased design and results lead to inappropriate conclusion
    Ke-Da Yu
    Bin Li
    Ying Zhou
    Zhi-Ming Shao
    Breast Cancer Research and Treatment, 2011, 128 : 297 - 300
  • [22] The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
    O M Sinilnikova
    A C Antoniou
    J Simard
    S Healey
    M Léoné
    D Sinnett
    A B Spurdle
    J Beesley
    X Chen
    M H Greene
    J T Loud
    F Lejbkowicz
    G Rennert
    S Dishon
    I L Andrulis
    S M Domchek
    K L Nathanson
    S Manoukian
    P Radice
    I Konstantopoulou
    I Blanco
    A L Laborde
    M Durán
    A Osorio
    J Benitez
    U Hamann
    F B L Hogervorst
    T A M van Os
    H J P Gille
    S Peock
    M Cook
    C Luccarini
    D G Evans
    F Lalloo
    R Eeles
    G Pichert
    R Davidson
    T Cole
    J Cook
    J Paterson
    C Brewer
    D J Hughes
    I Coupier
    S Giraud
    F Coulet
    C Colas
    F Soubrier
    E Rouleau
    I Bièche
    R Lidereau
    British Journal of Cancer, 2009, 101 : 1456 - 1460
  • [23] Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis
    Hongtao Cheng
    Biao Ma
    Ran Jiang
    Wei Wang
    Hui Guo
    Na Shen
    Dapeng Li
    Qunzi Zhao
    Rui Wang
    Pengfei Yi
    Yue Zhao
    Zeming Liu
    Tao Huang
    Molecular Biology Reports, 2012, 39 : 9265 - 9274
  • [24] Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis
    Cheng, Hongtao
    Ma, Biao
    Jiang, Ran
    Wang, Wei
    Guo, Hui
    Shen, Na
    Li, Dapeng
    Zhao, Qunzi
    Wang, Rui
    Yi, Pengfei
    Zhao, Yue
    Liu, Zeming
    Huang, Tao
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (09) : 9265 - 9274
  • [25] The TP53 Arg72Pro and MDM2 309G &gt; T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Sinilnikova, O. M.
    Antoniou, A. C.
    Simard, J.
    Healey, S.
    Leone, M.
    Sinnett, D.
    Spurdle, A. B.
    Beesley, J.
    Chen, X.
    Greene, M. H.
    Loud, J. T.
    Lejbkowicz, F.
    Rennert, G.
    Dishon, S.
    Andrulis, I. L.
    Domchek, S. M.
    Nathanson, K. L.
    Manoukian, S.
    Radice, P.
    Konstantopoulou, I.
    Blanco, I.
    Laborde, A. L.
    Duran, M.
    Osorio, A.
    Benitez, J.
    Hamann, U.
    Hogervorst, F. B. L.
    van Os, T. A. M.
    Gille, H. J. P.
    Peock, S.
    Cook, M.
    Luccarini, C.
    Evans, D. G.
    Lalloo, F.
    Eeles, R.
    Pichert, G.
    Davidson, R.
    Cole, T.
    Cook, J.
    Paterson, J.
    Brewer, C.
    Hughes, D. J.
    Coupier, I.
    Giraud, S.
    Coulet, F.
    Colas, C.
    Soubrier, F.
    Rouleau, E.
    Bieche, I.
    Lidereau, R.
    BRITISH JOURNAL OF CANCER, 2009, 101 (08) : 1456 - 1460
  • [26] The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies
    Tian, Xin
    Dai, Shundong
    Sun, Jing
    Jiang, Shenyi
    Jiang, Youhong
    ONCOTARGET, 2017, 8 (01) : 1156 - U1969
  • [27] The significance of G/C polymorphism of the RAD51 gene in postmenopausal women with breast cancer
    Romanowicz-Makowska, Hanna
    Smolarz, Beata
    Sobczuk, Anna
    Pertynskl, Tomasz
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2008, 7 (01): : 38 - 41
  • [28] Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer
    Trifa, Fatma
    Karray-Chouayekh, Sondes
    Mabrouk, Imed
    Baccouche, Sami
    Khabir, Abdelmajid
    Sellami-Boudawara, Tahia
    Gargouri, Ali
    Mokdad-Gargouri, Raja
    CANCER EPIDEMIOLOGY, 2010, 34 (02) : 184 - 188
  • [29] Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk
    Pei-Hua Lu
    Chen Li
    Hong-Yi Zhou
    Tong Wang
    Chun-Qiang Chu
    Wei Shen
    Guo-Qing Tao
    Breast Cancer Research and Treatment, 2011, 125 : 299 - 300
  • [30] Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk
    Lu, Pei-Hua
    Li, Chen
    Zhou, Hong-Yi
    Wang, Tong
    Chu, Chun-Qiang
    Shen, Wei
    Tao, Guo-Qing
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 299 - 300